Geibe v. O'Malley

CourtDistrict Court, M.D. Pennsylvania
DecidedJune 3, 2025
Docket1:24-cv-01400
StatusUnknown

This text of Geibe v. O'Malley (Geibe v. O'Malley) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Geibe v. O'Malley, (M.D. Pa. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF PENNSYLVANIA

JULIE GEIBE, : Civ. No. 1:24-CV-1400 : Plaintiff : : v. : : (Chief Magistrate Judge Bloom) FRANK BISIGNANO, : Commissioner of Social Security,1 : : Defendant :

MEMORANDUM OPINION

I. Introduction Julie Geibe filed a Title II application for a period of disability and disability insurance benefits on April 12, 2021. (Tr. 15). Following a hearing before an Administrative Law Judge (“ALJ”), the ALJ found that Geibe was not disabled from her alleged onset date of disability of March 29, 2021, through September 8, 2023, the date of the ALJ’s decision. (Tr. 15).

1 On May 7, 2025, Frank Bisignano became the Commissioner of Social Security. Pursuant to Rule 25(d) of the Federal Rules of Civil Procedure and 42 U.S.C. § 405(g), Frank Bisignano is substituted as the defendant in this suit. Giebe now appeals this decision, arguing that the ALJ’s decision is not supported by substantial evidence. After a review of the record, and

mindful of the fact that substantial evidence “means only—‘such relevant evidence as a reasonable mind might accept as adequate to support a conclusion,’” , 139 S. Ct. 1148, 1154 (2019), we

conclude that substantial evidence supported the ALJ’s findings in this case. Therefore, we will affirm the decision of the Commissioner denying

this claim. II. Statement of Facts and of the Case

On April 12, 2021, Geibe applied for disability insurance benefits, citing an array of physical and mental impairments, including, , blurred vision, double vision, depression, diabetes, stage 3 uterine cancer resulting in that organ’s removal, and high blood pressure. (Tr. 364).

Geibe was 59 years old at the time of the alleged onset of disability, had at least a high school education, and had past employment as a nurse aide, office clerk, and administrative assistant. (Tr. 24).

With respect to these alleged impairments the record revealed the following: Geibe first reported blurry vision, along with eye pain and head

2 pain, in March of 2021. (Tr. 571). Dr. Erik Ketels first diagnosed Geibe only with vision changes. (Tr. 573). But her symptoms apparently

worsened, as shortly thereafter, Geibe was hospitalized for two days with bilateral retinal hemorrhages and exudates. (Tr. 616). MRIs of her spine showed marked bilateral foraminal narrowing at L5-S1. (Tr. 593-95).

In April of 2021, Geibe reported blurry and double vision to Dr. Maxwell Stern at Pennsylvania Retina Specialists (“PRS”). (Tr. 613). Dr.

Stern diagnosed Geibe with branch retinal vein occlusion, type two diabetes with ocular complications, moderate non-proliferative diabetic retinopathy in both eyes, third nerve palsy, and nuclear sclerosis in both

eyes. (Tr. 614). He also gave Geibe an ocular injection of aflibercept. (Tr. 615). Later that month, Geibe met with Dr. Anne Hayes at Lebanon Internal Medicine and reported feeling “terrible” due to continued eye

and leg pain. (Tr. 586-87). Dr. Hayes diagnosed Geibe with bilateral retinal hemorrhages, type two diabetes mellitus with hyperglycemia, malignant neoplasm of endometrium, obesity, leg pain, and

hypertension. (Tr. 587-89). Geibe consulted with Dr. Hayes again in May

3 2021, and reported right eye heaviness and swelling, as well as pain in both her legs and her groin. (Tr. 633).

Geibe continued to report vision problems, next to Dr. George Fava at PRS in November 2021. (Tr. 814). She described an inability to focus, a feeling that her right eye was “pulling,” and numbness. ( ). Dr. Fava

recommended a retinal injection. ( ). Later that month, Geibe underwent nerve conduction studies and an EMG at Hershey Medical

Center, which showed evidence of L5-S1 chronic radiculopathy. (Tr. 866- 69). In August of 2022, Geibe reported haloes and glare in her vision. (Tr. 954). Dr. Fava diagnosed Geibe with branch retinal vein occlusion

with macular edema in the left eye, type two diabetes with ocular complications, moderate non-proliferative diabetic retinopathy in both eyes, and worsening nuclear sclerosis in both eyes. (Tr. 954). Dr. Fava

noted that Geibe’s third nerve palsy, as well as her eye pain and numbness, had resolved. ( .). It is against this factual backdrop that the ALJ conducted three

hearings in Geibe’s case, on April 18, 2022, February 3, 2023, and September 15, 2023. (Tr. 33, 66, 101). Geibe and a vocational expert

4 (“VE”) both testified at the April 2022 hearing. Geibe testified about her 2020 cancer diagnosis, her ensuing surgery, and the health problems that

developed thereafter, particularly her vision issues. (Tr. 108-23). The VE also testified, classifying Geibe’s past work and answering hypothetical questions about what occupations a person with Geibe’s

background and certain specific limitations could perform. (Tr. 124-30). At the second hearing, in February 2023, Geibe testified again, along

with a medical expert (“ME”) who also acted as the VE for that hearing. (Tr. 66-100). The ME testified first and discussed the details of Geibe’s medical record, her progress, and prognosis. (Tr. 69-90). Geibe then

testified about the changes to her vision and the medical advice she had been given about future management of her eyesight. (Tr. 90-100). At the final hearing, in September of 2023, both the VE and ME returned to

testify. The ME testified about new medical evidence added to the record since his previous testimony. (Tr. 37-50). The ME recommended a limitation he had not before: that Geibe could not use a needle and

thread. (Tr. 40). The VE then testified about the effect of that limitation on Geibe’s hypothetical employment. (Tr. 41-55).

5 Following the third hearing, on September 28, 2023, the ALJ issued a decision denying Geibe’s application for benefits. (Tr. 15-25). In that

decision, the ALJ first concluded that Geibe met the insured status requirement through December 31, 2026. (Tr. 18). At Step 2 of the sequential analysis that governs Social Security cases, the ALJ found

Geibe suffered from one severe impairment: branch retinal vein occlusion with macular edema of the left eye. ( ). At Step 3 the ALJ determined

that Geibe did not have an impairment or combination of impairments that met or medically equaled the severity of one of the listed impairments. (Tr. 19).

Between Steps 3 and 4 the ALJ concluded that, from the alleged onset date of March 28, 2021, to February 1, 2023, Geibe retained the residual functional capacity to:

[P]erform a full range of work at all exertional levels but with the following nonexertional limitations: no postural limitations except no climbing ladders, ropes, or scaffolds; no exposure to unprotected heights, moving machinery parts, and driving; and visual limitations of no determining difference in shape and color of small objects, such as screws, nuts, or bolt, no bright sunlight but indoor lighting, including fluorescent lighting, is acceptable. She can read standard computer font, read normal book and newspaper print but not small print on medication bottles. 6 (Tr. 19-20).

In reaching this RFC determination, the ALJ made the following findings: the ALJ considered Geibe’s reported, subjective symptoms, and found that “claimant’s medically determinable impairments could reasonably be expected to cause some of the alleged symptoms; however,

the claimant’s statements concerning the intensity, persistence and limiting effects of these symptoms are not entirely consistent with the medical evidence and other evidence in the record [.]” (Tr. 20). The ALJ

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Consolo v. Federal Maritime Commission
383 U.S. 607 (Supreme Court, 1966)
Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Pierce v. Underwood
487 U.S. 552 (Supreme Court, 1988)
Shinseki, Secretary of Veterans Affairs v. Sanders
556 U.S. 396 (Supreme Court, 2009)
Kacee Chandler v. Commissioner Social Security
667 F.3d 356 (Third Circuit, 2011)
Diaz v. Commissioner of Social Security
577 F.3d 500 (Third Circuit, 2009)
Johnson v. Commissioner of Social Security
529 F.3d 198 (Third Circuit, 2008)
Burton v. Schweiker
512 F. Supp. 913 (W.D. Pennsylvania, 1981)
Leslie v. Barnhart
304 F. Supp. 2d 623 (M.D. Pennsylvania, 2003)
Roseann Zirnsak v. Commissioner Social Security
777 F.3d 607 (Third Circuit, 2014)
Titterington v. Comm Social Security
174 F. App'x 6 (Third Circuit, 2006)
Biestek v. Berryhill
587 U.S. 97 (Supreme Court, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Geibe v. O'Malley, Counsel Stack Legal Research, https://law.counselstack.com/opinion/geibe-v-omalley-pamd-2025.